RIL
ANIP icon

Rothschild Investment LLC’s ANI Pharmaceuticals ANIP Stock Holding History

Rothschild Investment LLC’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Buy
26
+6
+30% +$468 ﹤0.01% 2564
2025
Q4 		$1.58K Hold
20
– – ﹤0.01% 2484
2025
Q3 		$1.83K Hold
20
– – ﹤0.01% 2283
2025
Q2 		$1.3K Sell
20
-10
-33% -$651 ﹤0.01% 2320
2025
Q1 		$2.01K Buy
30
+15
+100% +$896 ﹤0.01% 1896
2024
Q4 		$829 Hold
15
– – ﹤0.01% 2324
2024
Q3 		$895 Buy
15
+10
+200% +$610 ﹤0.01% 2248
2024
Q2 		$318 Buy
+5
New +$325 ﹤0.01% 2267
2020
Q2 		– Sell
-5,063
Closed -$206K – 427
2020
Q1 		$206K Sell
5,063
-4,493
-47% -$239K 0.03% 369
2019
Q4 		$589K Buy
+9,556
New +$633K 0.06% 272

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return